1. RCGP and BMA update: information on the proposals for the prescription of inclisiran in primary care settings. December 2021. https://i.emlfiles4.com/cmpdoc/3/7/7/5/2/files/865466_inclisiran-statement-rcgp-bma-badged-dec-2021.pdf.
2. National Institute for Health and Care Excellence. Inclisiran for treating primary hypercholesterolemia or mixed dyslipidaemia. Final appraisal document. September 2021. www.nice.org.uk/guidance/indevelopment/gid-ta10703/documents.
3. NICE approves new cholesterol lowering drug after NHS strikes deal with manufacturer
4. NICE guidance on inclisiran should be reconsidered